People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | — | Biotechnology | Series C | $103.1M | $808.1M | 2021 |
| Benitec Biopharma Inc. | — | Biotechnology | Series C | $40.0M | $383.9M | 2024 |
Jerel Banks at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jerel Banks on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Victor Tong | 1 | 6 |
| Henry Ji | 1 | 5 |
| J Kevin Buchi | 1 | 3 |
| Zachary Hornby | 1 | 2 |
| Bob Shin | 1 | 1 |
| Peter Kevin Francis | 1 | 1 |
| Edward Kevin Smith | 1 | 1 |
| Megan Boston | 1 | 1 |
| Jeffrey Chi | 1 | 1 |
| Nelson Sun | 1 | 1 |
| Tien-Li Lee | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.